Sepsis, Severe Clinical Trial
Official title:
Is Neuromuscular Electrical Stimulator Treatment in Sepsis/ Septic Shock Patients Protective in the Development of Intensive Care Unit Acquired Muscle Weakness (ICU-AW)?
Background: Sarcopenia (muscle weakness) characterized by a decrease in muscle mass, strength and performance is a condition that increases with old age. Sarcopenia can be seen in 5-13% of patients hospitalized in ICU where various treatment methods are used to prevent this weakness, the rate increases in patients with sepsis/ septic shock. Muscle treatment methods are used to prevent sarcopenia in similar patients hospitalized in ICU. It is predicted that "neuromuscular electrical stimulator-NMES" treatment may increase muscle mass and strength in patients who's can not be exercised actively. In this study, the contribution of NMES treatment to prevent the development of muscle weakness in patients with a diagnosis of sepsis/ septic shock followed in intensive care units (ICU) was evaluated.
Background: Sarcopenia (muscle weakness) characterized by a decrease in muscle mass, strength and performance is a condition that increases with old age. Sarcopenia can be seen in 5-13% of patients hospitalized in ICU where various treatment methods are used to prevent this weakness, the rate increases in patients with sepsis/ septic shock. Muscle treatment methods are used to prevent sarcopenia in similar patients hospitalized in ICU. It is predicted that "neuromuscular electrical stimulator-NMES" treatment may increase muscle mass and strength in patients who's can not be exercised actively. In this study, the contribution of NMES treatment to prevent the development of muscle weakness in patients with a diagnosis of sepsis/ septic shock followed in intensive care units (ICU) was evaluated. Patients and methods: In our single-center, prospective clinical study, 80 patients with a diagnosis of sepsis/ septic shock who were hospitalized in ICU were included. The effects of NMES and muscle strengthening and standard physiotherapy exercises on the development of ICU-AW were observed. The day when our patients were diagnosed with sepsis was recorded as the first day of the study. Anthropometric and ultrasonographic measurements of bilateral biceps brachii and bilateral rectus femoris muscles were recorded on the following days i.e. 3, 7, 14, 21, and 28. Sarcopenia was defined by anthropometric and ultrasonographic measurement, and all patient outcome data were recorded. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04117568 -
The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients
|
||
| Recruiting |
NCT04796636 -
High-dose Intravenous Vitamin C in Patients With Septic Shock
|
Phase 1 | |
| Terminated |
NCT04134624 -
EMS Prehospital Blood Culture Collection and Antibiotic Administration: A Two-Phase Pilot Project to Reduce Mortality in Patients With Severe Sepsis and Septic Shock
|
N/A | |
| Withdrawn |
NCT04821414 -
Effects of IL-1β and Its Receptor Antagonists in the Treatment of Severe Infection and Inflammatory Storm in Children
|
||
| Recruiting |
NCT05357339 -
Microcirculation Properties of Albumin for Fluid Resuscitation in Septic Shock
|
N/A | |
| Recruiting |
NCT06178822 -
Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room
|
||
| Not yet recruiting |
NCT04105400 -
Procalcitonin in Diagnosis of Sepsis in Critically Ill Patient
|
||
| Completed |
NCT04459572 -
As an Early Indicator Biomarker of Prognosis and Mortality in Children With Sepsis and Septic Shock: suPAR
|
N/A | |
| Completed |
NCT04508296 -
The Effect pf Goal-directed De-escalation in ARDS on Organ Function and Mortality
|
N/A | |
| Recruiting |
NCT03685214 -
Comparison of Balanced Crystalloids and Normal Saline in Septic Patients
|
N/A | |
| Not yet recruiting |
NCT04850456 -
Treatment Strategy of Human Gamma Globulin on the Therapy for Intensively Ill Children With Inflammatory Storm
|
||
| Completed |
NCT04747795 -
Early Administration of Vitamin C in Patients With Sepsis or Septic Shock in Emergency Departments
|
Phase 3 | |
| Terminated |
NCT03821038 -
Recombinant Interleukin-7 (CYT107) to Restore Absolute Lymphocyte Counts in Sepsis Patients
|
Phase 2 | |
| Completed |
NCT05246969 -
Detecting Sepsis in Patients With Severe Subarachnoideal Hemorrhage
|
||
| Recruiting |
NCT05442710 -
Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy
|
Phase 2 | |
| Completed |
NCT05467605 -
Effect of Probiotics on Cytokines in Sepsis in Children
|
N/A | |
| Completed |
NCT03974386 -
Effects of Endotoxin Absorption and Cytokine Removal Hemofilter on Severe Septic Shock
|
N/A | |
| Recruiting |
NCT04203979 -
Sepsis: From Syndrome to Personalized Care
|
||
| Not yet recruiting |
NCT03367026 -
Reducing Elevated Heart Rate in Patients With Severe Sepsis by Ivabradine
|
N/A | |
| Recruiting |
NCT03244293 -
Bispectral Index (BIS) for Classification of Procalcitonin (PCT) Sepsis Grades in Critically Ill Patients With Sepsis
|